Northern Trust’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.56M Sell
136,496
-5,963
-4% -$112K ﹤0.01% 2846
2025
Q1
$2.56M Sell
142,459
-3,380
-2% -$60.8K ﹤0.01% 2791
2024
Q4
$2.45M Buy
145,839
+1,588
+1% +$26.7K ﹤0.01% 2908
2024
Q3
$2.33M Buy
144,251
+4,182
+3% +$67.7K ﹤0.01% 2904
2024
Q2
$1.15M Sell
140,069
-4,706
-3% -$38.7K ﹤0.01% 3183
2024
Q1
$2.14M Sell
144,775
-9,385
-6% -$139K ﹤0.01% 2921
2023
Q4
$2.24M Buy
154,160
+2,397
+2% +$34.8K ﹤0.01% 2937
2023
Q3
$1.64M Buy
151,763
+424
+0.3% +$4.58K ﹤0.01% 3046
2023
Q2
$1.95M Sell
151,339
-591
-0.4% -$7.62K ﹤0.01% 3020
2023
Q1
$2.01M Buy
151,930
+1,009
+0.7% +$13.3K ﹤0.01% 2933
2022
Q4
$2.26M Sell
150,921
-10,647
-7% -$160K ﹤0.01% 2942
2022
Q3
$1.91M Sell
161,568
-2,955
-2% -$34.9K ﹤0.01% 3037
2022
Q2
$1.86M Sell
164,523
-5,500
-3% -$62.1K ﹤0.01% 3107
2022
Q1
$5.08M Sell
170,023
-7,923
-4% -$237K ﹤0.01% 2578
2021
Q4
$4.72M Buy
177,946
+2,239
+1% +$59.3K ﹤0.01% 2711
2021
Q3
$6.38M Sell
175,707
-4,220
-2% -$153K ﹤0.01% 2580
2021
Q2
$7.81M Sell
179,927
-7,135
-4% -$310K ﹤0.01% 2543
2021
Q1
$6.4M Sell
187,062
-9,885
-5% -$338K ﹤0.01% 2590
2020
Q4
$6.89M Sell
196,947
-2,133
-1% -$74.6K ﹤0.01% 2486
2020
Q3
$4.78M Sell
199,080
-12,130
-6% -$291K ﹤0.01% 2560
2020
Q2
$3.87M Sell
211,210
-935
-0.4% -$17.1K ﹤0.01% 2673
2020
Q1
$3.31M Sell
212,145
-1,993
-0.9% -$31.1K ﹤0.01% 2552
2019
Q4
$4.58M Buy
214,138
+5,382
+3% +$115K ﹤0.01% 2635
2019
Q3
$3.9M Buy
208,756
+5,513
+3% +$103K ﹤0.01% 2688
2019
Q2
$5.31M Buy
203,243
+2,393
+1% +$62.5K ﹤0.01% 2529
2019
Q1
$5.16M Sell
200,850
-264
-0.1% -$6.79K ﹤0.01% 2543
2018
Q4
$4.63M Sell
201,114
-4,121
-2% -$94.8K ﹤0.01% 2552
2018
Q3
$6.59M Buy
205,235
+5,598
+3% +$180K ﹤0.01% 2526
2018
Q2
$5.65M Buy
199,637
+21,993
+12% +$622K ﹤0.01% 2626
2018
Q1
$6.29M Buy
177,644
+3,684
+2% +$130K ﹤0.01% 2450
2017
Q4
$6.75M Buy
173,960
+25,006
+17% +$970K ﹤0.01% 2427
2017
Q3
$3.78M Buy
148,954
+2,202
+2% +$55.9K ﹤0.01% 2810
2017
Q2
$4.01M Buy
146,752
+10,614
+8% +$290K ﹤0.01% 2753
2017
Q1
$4.51M Buy
136,138
+25,459
+23% +$843K ﹤0.01% 2612
2016
Q4
$2.63M Buy
110,679
+7,359
+7% +$175K ﹤0.01% 2940
2016
Q3
$3.79M Buy
103,320
+1,180
+1% +$43.3K ﹤0.01% 2700
2016
Q2
$2.28M Buy
102,140
+6,816
+7% +$152K ﹤0.01% 2962
2016
Q1
$1.98M Buy
95,324
+1,013
+1% +$21.1K ﹤0.01% 2988
2015
Q4
$2.86M Buy
94,311
+3,299
+4% +$100K ﹤0.01% 2830
2015
Q3
$2.25M Buy
91,012
+6,206
+7% +$153K ﹤0.01% 2985
2015
Q2
$2.72M Sell
84,806
-3,371
-4% -$108K ﹤0.01% 2898
2015
Q1
$3.15M Sell
88,177
-1,880
-2% -$67.1K ﹤0.01% 2814
2014
Q4
$2.04M Sell
90,057
-6,182
-6% -$140K ﹤0.01% 3091
2014
Q3
$1.87M Sell
96,239
-8,044
-8% -$156K ﹤0.01% 3149
2014
Q2
$3.79M Sell
104,283
-7,755
-7% -$282K ﹤0.01% 2714
2014
Q1
$4.35M Sell
112,038
-10,159
-8% -$394K ﹤0.01% 2651
2013
Q4
$3.48M Buy
122,197
+3,199
+3% +$91.2K ﹤0.01% 2796
2013
Q3
$4.26M Sell
118,998
-2,992
-2% -$107K ﹤0.01% 2616
2013
Q2
$4.07M Buy
+121,990
New +$4.07M ﹤0.01% 2549